GlassScriptPhysician profile
Timothy M Clark
NPI 1043265663
$581.81
in general payments reported to CMS, 2019-2025
11 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $39.15 · 2021: $2.50 · 2022: $102 · 2023: $79.37 · 2024: $20.94 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245 · Education: $14.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.30 |
| Education | $14.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $126.92 | 2020-2023 | Uptravi, Opsumit |
| Insmed, INC. | $116.23 | 2019-2022 | |
| Cook Medical LLC | $114.44 | 2025 | Cook |
| Genentech USA, INC. | $77.95 | 2019 | |
| Resmed Corp | $31.78 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $28.53 | 2025 | Lumryz |
| Boston Scientific Corporation | $28.11 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.94 | 2024 | |
| Pulmonx Corporation | $17.36 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Itamar Medical INC | $17.05 | 2023 | Watchpatone |
| United Therapeutics Corporation | $2.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.